Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Hsa-miR-375 is a predictor of local control in early stage breast cancer.

Zehentmayr F, Hauser-Kronberger C, Zellinger B, Hlubek F, Schuster C, Bodenhofer U, Fastner G, Deutschmann H, Steininger P, Reitsamer R, Fischer T, Sedlmayer F.

Clin Epigenetics. 2016 Mar 8;8:28. doi: 10.1186/s13148-016-0198-1. eCollection 2016.

2.

Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues.

Schuster C, Malinowsky K, Liebmann S, Berg D, Wolff C, Tran K, Schott C, Reu S, Neumann J, Faber C, Höfler H, Kirchner T, Becker KF, Hlubek F.

Histopathology. 2012 May;60(6B):E37-50. doi: 10.1111/j.1365-2559.2012.04184.x. Epub 2012 Mar 6.

PMID:
22393911
3.

Overexpression of Dicer predicts poor survival in colorectal cancer.

Faber C, Horst D, Hlubek F, Kirchner T.

Eur J Cancer. 2011 Jun;47(9):1414-9. doi: 10.1016/j.ejca.2011.01.006. Epub 2011 Feb 21.

PMID:
21345667
4.

Multicentre validation study of nucleic acids extraction from FFPE tissues.

Bonin S, Hlubek F, Benhattar J, Denkert C, Dietel M, Fernandez PL, Höfler G, Kothmaier H, Kruslin B, Mazzanti CM, Perren A, Popper H, Scarpa A, Soares P, Stanta G, Groenen PJ.

Virchows Arch. 2010 Sep;457(3):309-17. doi: 10.1007/s00428-010-0917-5. Epub 2010 Jul 28.

5.

MicroRNA expression profiling of specific cells in complex archival tissue stained by immunohistochemistry.

Schuster C, Budczies J, Faber C, Kirchner T, Hlubek F.

Lab Invest. 2011 Jan;91(1):157-65. doi: 10.1038/labinvest.2010.134. Epub 2010 Jul 26.

6.

Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.

Horst D, Budczies J, Brabletz T, Kirchner T, Hlubek F.

Cancer. 2009 Nov 1;115(21):4946-58. doi: 10.1002/cncr.24564.

7.

The impact of microRNAs on colorectal cancer.

Faber C, Kirchner T, Hlubek F.

Virchows Arch. 2009 Apr;454(4):359-67. doi: 10.1007/s00428-009-0751-9. Epub 2009 Mar 14. Review.

PMID:
19288129
8.

p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors.

Wassermann S, Scheel SK, Hiendlmeyer E, Palmqvist R, Horst D, Hlubek F, Haynl A, Kriegl L, Reu S, Merkel S, Brabletz T, Kirchner T, Jung A.

Gastroenterology. 2009 Jan;136(1):196-205.e2. doi: 10.1053/j.gastro.2008.09.019. Epub 2008 Sep 20.

PMID:
18951899
9.

Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.

Spaderna S, Schmalhofer O, Hlubek F, Jung A, Kirchner T, Brabletz T.

Verh Dtsch Ges Pathol. 2007;91:21-8.

PMID:
18314592
10.

The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.

Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, Kirchner T, Behrens J, Brabletz T.

Cancer Res. 2008 Jan 15;68(2):537-44. doi: 10.1158/0008-5472.CAN-07-5682.

11.

Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer.

Hlubek F, Brabletz T, Budczies J, Pfeiffer S, Jung A, Kirchner T.

Int J Cancer. 2007 Nov 1;121(9):1941-8.

12.

Wnt/FZD signaling and colorectal cancer morphogenesis.

Hlubek F, Spaderna S, Schmalhofer O, Jung A, Kirchner T, Brabletz T.

Front Biosci. 2007 Jan 1;12:458-70. Review.

PMID:
17127310
13.

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A, Kirchner T, Brabletz T.

Gastroenterology. 2006 Sep;131(3):830-40.

PMID:
16952552
14.

Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma.

Hlubek F, Pfeiffer S, Budczies J, Spaderna S, Jung A, Kirchner T, Brabletz T.

Br J Cancer. 2006 Jun 5;94(11):1672-7.

15.

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T.

Nat Rev Cancer. 2005 Sep;5(9):744-9. Review.

PMID:
16148886
16.

beta-Catenin regulates the expression of tenascin-C in human colorectal tumors.

Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knoll C, Kirchner T, Jung A.

Oncogene. 2005 Dec 8;24(55):8200-4.

PMID:
16091738
17.

Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.

Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T.

Cells Tissues Organs. 2005;179(1-2):56-65. Review.

PMID:
15942193
18.

Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression.

Brabletz T, Spaderna S, Kolb J, Hlubek F, Faller G, Bruns CJ, Jung A, Nentwich J, Duluc I, Domon-Dell C, Kirchner T, Freund JN.

Cancer Res. 2004 Oct 1;64(19):6973-7.

19.

Evidence for acid-induced loss of Cdx2 expression in duodenal gastric metaplasia.

Faller G, Dimmler A, Rau T, Spaderna S, Hlubek F, Jung A, Kirchner T, Brabletz T.

J Pathol. 2004 Aug;203(4):904-8.

PMID:
15258992
20.

Tissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification.

Croner RS, Guenther K, Foertsch T, Siebenhaar R, Brueckl WM, Stremmel C, Hlubek F, Hohenberger W, Reingruber B.

J Lab Clin Med. 2004 Jun;143(6):344-51.

PMID:
15192650
21.

Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors.

Hiendlmeyer E, Regus S, Wassermann S, Hlubek F, Haynl A, Dimmler A, Koch C, Knoll C, van Beest M, Reuning U, Brabletz T, Kirchner T, Jung A.

Cancer Res. 2004 Feb 15;64(4):1209-14.

22.

Transcription of sonic hedgehog, a potential factor for gastric morphogenesis and gastric mucosa maintenance, is up-regulated in acidic conditions.

Dimmler A, Brabletz T, Hlubek F, Häfner M, Rau T, Kirchner T, Faller G.

Lab Invest. 2003 Dec;83(12):1829-37.

PMID:
14691301
23.
24.

Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin.

Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T.

Cancer Res. 2001 Nov 15;61(22):8089-93.

25.

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.

Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61.

26.

Tip60 is a cell-type-specific transcriptional regulator.

Hlubek F, Löhberg C, Meiler J, Jung A, Kirchner T, Brabletz T.

J Biochem. 2001 Apr;129(4):635-41.

27.

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T.

Am J Pathol. 1999 Oct;155(4):1033-8.

28.

Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB.

Brabletz T, Jung A, Hlubek F, Löhberg C, Meiler J, Suchy U, Kirchner T.

Int Immunol. 1999 Oct;11(10):1701-8.

PMID:
10508188
29.

Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.

Chuvpilo S, Avots A, Berberich-Siebelt F, Glöckner J, Fischer C, Kerstan A, Escher C, Inashkina I, Hlubek F, Jankevics E, Brabletz T, Serfling E.

J Immunol. 1999 Jun 15;162(12):7294-301.

Supplemental Content

Loading ...
Support Center